Gastrointestinal Therapeutics Market: By Drug Glass (Antacids, Laxatives, Antidiarrheal agents, Antiemetics, Antiulcer agents and Others), Mode of Administration (Oral, Intravenous and Others), Application (Gastroenteritis, Gastrointestinal Bleeding, Irritable Bowel Syndrome, and Peptic Ulcer Disease), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and others) and Geography  

Purchase Option

$ 4400
$ 6600
$ 8900

Gastrointestinal Therapeutics Market size was valued at USD 52.8 billion in 2022, growing at a CAGR of 6.9% from 2023 to 2029. The global market provides a detailed overview of the Gastrointestinal Therapeutics market, and that can be segmented by drug, by mode of administration, by application, and by Distribution channel. By drug, the Gastrointestinal Therapeutics market has been segmented into antacids, Laxatives, Antidiarrheal agents, Antiemetics, Antiulcer agents, and Others. The Laxatives segment is likely to be the significant growing segment in drugs. Based on the Mode of administration, the Gastrointestinal Therapeutics market is segmented into Oral, Intravenous, and Others. Among these, the Intravenous segment is expected to have the fastest-growing market during the forecast period 2022-2028. The considerable share is expected to be an outcome of the advantages related to IV products. It can also be due to the high price of IV products compared to oral care products. Based on the application, the Gastrointestinal Therapeutics market is segmented into Gastroenteritis, Gastrointestinal Bleeding, Irritable Bowel Syndrome, and Peptic Ulcer. The Gastroenteritis Gastrointestinal Bleeding segment is expected to have a significant share in 2021. The rise of this segment is mainly because it offers an extensive range of applications for which gastrointestinal medicines have been used steadily over the prior years. Recurrent drug launches is also accountable for increased scope for development. Based on the Distribution channel, the Gastrointestinal Therapeutics market is segmented into Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others. The Retail Pharmacies segment is expected to have a significant share in 2021. The rise of this segment is mainly because of the convenience and high affordability of retail stores. As the number of prescription drugs being compensated grows, it inspires patients to buy medicines from retail pharmacies. Retail pharmacists also endorse drug alternatives that avoid severe drug interactions.

Key Developments:

In February 2021, in the United States, Lansoprazole delayed-release orally disintegrating tablets were launched by Dr. Reddy's Laboratories. In March 2020, Sebela Pharmaceuticals got approval from FDA for Pizensy (lactitol) for curing chronic idiopathic constipation (CIC) in adults.

Gastrointestinal Therapeutics Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

6.9%

Largest Market

North America

Fastest Growing Market

Asia Pacific
Gastrointestinal Therapeutics Market Dynimics

The growing incidence of gastrointestinal diseases is anticipated to propel the market growth over the forecast years. Moreover, the increasing clinical trials with promising results and increasing expenditure on healthcare are burgeoning the market growth over the forecast years.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Gastrointestinal Therapeutics Market Segmentation

By Drug Class
  • Antacids
  • Laxatives
  • Antidiarrheal agents
  • Antiemetics
  • Antiulcer agents
  • Others
By Mode Administration
  • Oral
  • Intravenous
  • Others
By Application
  • Gastroenteritis
  • Gastrointestinal Bleeding
  • Irritable Bowel Syndrome
  • Peptic Ulcer Disease
By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • others

Frequently Asked Questions

The gastrointestinal therapeutics market size was valued at USD 52.8 billion in 2022

The gastrointestinal therapeutics market key players are: Abbott Laboratories (US) Allergan (Ireland) AstraZeneca plc (UK) GlaxoSmithKline Plc (UK) Takeda Pharmaceutical Company Limited (Japan) Pfizer Inc. (US) Bayer AG (Germany) Bausch Health (Canada) Merck & Co., Inc. (US) AbbVie Inc. (US)

The gastrointestinal therapeutics market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.

  1. Executive Summary
  2. Global Gastrointestinal Therapeutics Market Introduction
    • Global Gastrointestinal Therapeutics Market Taxonomy
    • Global Gastrointestinal Therapeutics Market Definitions
      • By Drug Type
      • By Product
      • By Route of Administration
      • By Application
      • By Distribution Channel
      • By Region
  1. Global Gastrointestinal Therapeutics Market Dynamics
    • Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
    • Global Gastrointestinal Therapeutics Market Dynamic Factors - Impact Analysis
    • Global Gastrointestinal Therapeutics Market Competition Landscape
  2. Global Gastrointestinal Therapeutics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029
    • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Market Opportunity Analysis
  3. Global Gastrointestinal Therapeutics Market, By Drug Type, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
    • Antacids
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Laxatives
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Antidiarrheal agents
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Antiemetics
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Antiulcer agents
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Gastrointestinal Therapeutics Market Forecast, By Product Type, 2018 - 2022 and Forecast, 2023 - 2029
    • Prescription based therapeutics
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • OTC therapeutics
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Gastrointestinal Therapeutics Market Forecast, By Product, Route of Administration, 2018 - 2022 and Forecast, 2023 - 2029
    • Oral
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Intravenous
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Gastrointestinal Therapeutics Market, By Application, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
    • Ulcerative Colitis
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Crohn’s Disease
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • GERD
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Irritable Bowel Syndrome
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Peptic Ulcer Disease (PUD)
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Gastrointestinal Therapeutics Market Forecast, By Distribution Channel, 2018 - 2022 and Forecast, 2023 - 2029
    • Hospital Pharmacies
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Retail Pharmacies
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Online Pharmacies
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Gastrointestinal Therapeutics Market Forecast, By Region, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
    • North America
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Europe
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Asia-Pacific
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Latin America
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Middle East and Africa
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Global Gastrointestinal Therapeutics Market - Opportunity Analysis Index, By Drug Type, Product, Route of Administration, Application, Distribution Channel, and Region, 2023 - 2029
  2. North America Gastrointestinal Therapeutics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
    • By Drug Type, 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Antacids
      • laxatives
      • Antidiarrheal agents
      • Antiemetics
      • Antiulcer agents
      • Others
    • By Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Prescription based therapeutics
      • OTC therapeutics
    • By Route of Administration Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oral
      • Intravenous
      • Others
    • By Application, 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Ulcerative Colitis
      • Crohn’s Disease
      • GERD
      • Irritable Bowel Syndrome
      • Peptic Ulcer Disease (PUD)
      • Others
    • By Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • Others
    • Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • US
      • Canada
    • North America Gastrointestinal Therapeutics Market - Opportunity Analysis Index, By Drug Type, Product, Route of Administration, Application, Distribution Channel, and Country, 2023 - 2029
    • North America Gastrointestinal Therapeutics Market Dynamics Trends
  3. Europe Gastrointestinal Therapeutics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
    • By Drug Type, 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Antacids
      • laxatives
      • Antidiarrheal agents
      • Antiemetics
      • Antiulcer agents
      • Others
    • By Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Prescription based therapeutics
      • OTC therapeutics
    • By Route of Administration Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oral
      • Intravenous
      • Others
    • By Application, 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Ulcerative Colitis
      • Crohn’s Disease
      • GERD
      • Irritable Bowel Syndrome
      • Peptic Ulcer Disease (PUD)
      • Others
    • By Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • Others
    • Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Germany
      • UK
      • France
      • Spain
      • Italy
      • Russia
      • Poland
      • Rest of Europe
    • Europe Gastrointestinal Therapeutics Market - Opportunity Analysis Index, By Drug Type, Product, Route of Administration, Application, Distribution Channel, and Country, 2023 - 2029
    • Europe Gastrointestinal Therapeutics Market Dynamics Trends
  4. Asia-Pacific Gastrointestinal Therapeutics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
    • By Drug Type, 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Antacids
      • laxatives
      • Antidiarrheal agents
      • Antiemetics
      • Antiulcer agents
      • Others
    • By Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Prescription based therapeutics
      • OTC therapeutics
    • By Route of Administration Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oral
      • Intravenous
      • Others
    • By Application, 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Ulcerative Colitis
      • Crohn’s Disease
      • GERD
      • Irritable Bowel Syndrome
      • Peptic Ulcer Disease (PUD)
      • Others
    • By Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • Others
    • Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Japan
      • China
      • India
      • ASEAN
      • Australia & New Zealand
      • Rest of Asia-Pacific
    • Asia-Pacific Gastrointestinal Therapeutics Market - Opportunity Analysis Index, By Drug Type, Product, Route of Administration, Application, Distribution Channel, and Country, 2023 - 2029
    • Asia-Pacific Gastrointestinal Therapeutics Market Dynamics Trends
  5. Latin America Gastrointestinal Therapeutics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
    • By Drug Type, 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Antacids
      • laxatives
      • Antidiarrheal agents
      • Antiemetics
      • Antiulcer agents
      • Others
    • By Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Prescription based therapeutics
      • OTC therapeutics
    • By Route of Administration Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oral
      • Intravenous
      • Others
    • By Application, 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Ulcerative Colitis
      • Crohn’s Disease
      • GERD
      • Irritable Bowel Syndrome
      • Peptic Ulcer Disease (PUD)
      • Others
    • By Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • Others
    • Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Brazil
      • Mexico
      • Argentina
      • Venezuela
      • Rest of Latin America
    • Latin America Gastrointestinal Therapeutics Market - Opportunity Analysis Index, By Drug Type, Product, Route of Administration, Application, Distribution Channel, and Country, 2023 - 2029
    • Latin America Gastrointestinal Therapeutics Market Dynamics Trends
  6. Middle East and Africa Gastrointestinal Therapeutics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
    • By Drug Type, 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Antacids
      • laxatives
      • Antidiarrheal agents
      • Antiemetics
      • Antiulcer agents
      • Others
    • By Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Prescription based therapeutics
      • OTC therapeutics
    • By Route of Administration Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oral
      • Intravenous
      • Others
    • By Application, 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Ulcerative Colitis
      • Crohn’s Disease
      • GERD
      • Irritable Bowel Syndrome
      • Peptic Ulcer Disease (PUD)
      • Others
    • By Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • Others
    • Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Gulf Cooperation Council (GCC) Countries
      • Israel
      • South Africa
      • Rest of MEA
    • MEA Gastrointestinal Therapeutics Market - Opportunity Analysis Index, By Drug Type, Product, Route of Administration, Application, Distribution Channel, and Country, 2023 - 2029
    • MEA Gastrointestinal Therapeutics Market Dynamics Trends
  7. Competition Landscape
    • Strategic Dashboard of Top Market Players
    • Company Profiles (Introduction, Financial Analysis, Service Offerings, Key Developments, Strategies, and SWOT Analysis)
      • Abbott Laboratories (US)
      • Allergan (Ireland)
      • AstraZeneca plc (UK)
      • GlaxoSmithKline Plc (uk)
      • Takeda Pharmaceutical Company Limited (Japan)
      • Pfizer Inc (US)
      • Bayer AG (Germany)
      • Bausch Health (Canada)
      • Merck & Co., Inc. (US)
      • AbbVie Inc. (US)
  1. Research Methodology
  2. Key Assumptions and Acronyms
  • Abbott Laboratories (US)
  • Allergan (Ireland)
  • AstraZeneca plc (UK)
  • GlaxoSmithKline Plc (UK)
  • Takeda Pharmaceutical Company Limited (Japan)
  • Pfizer Inc. (US)
  • Bayer AG (Germany)
  • Bausch Health (Canada)
  • Merck & Co., Inc. (US)
  • AbbVie Inc. (US)

Adjacent Markets